Hoechst 33342
Based on 141 publication(s) in Google Scholar
Hoechst 33342 is a marker dye in Hoechst series. Hoechst is A live nuclear marker dye. Hoechst binds to the grooves in the DNA double strand, which tends to be A/ T-rich DNA strand. Although it binds to all nucleic acids, the A/ T-rich double strand DNA significantly enhances fluorescence intensity Therefore,Hoechst dye can be used for living cell labeling. The fluorescence intensity of Hoechst dye increases with the increase of pH of solution.
For research use only. We do not sell to patients.
- Purity: 99.52%
- CAS No.: 23491-52-3
- Formula: C27H28N6O
- Molecular Weight:452.55
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications Citing Use of MedChemExpress (MCE) Hoechst 33342
More- Science. 2025 Dec 11;390(6778):1143-1150. [Abstract]
- Science. 2022 Nov 18;378(6621):eabq7361. [Abstract]
- Cell. 2026 Feb 5;189(3):887-905.e25. [Abstract]
- Immunity. 2025 Mar 21:S1074-7613(25)00093-7. [Abstract]
- Drug Resist Updat. 2024 Jun 14:76:101111. [Abstract]
- Sci Bull. 2025 Aug 11:S2095-9273(25)00813-8. [Abstract]
- Bioact Mater. 2022 Mar 17;18:91-103. [Abstract]
- Adv Funct Mater. 2025 Sep 23.
- Adv Funct Mater. 2025 Sep 19.
- Adv Funct Mater. 2025 Feb 19.
- Cell Host Microbe. 2026 Jan 14;34(1):86-102.e8. [Abstract]
- Cell Host Microbe. 2023 Nov 8;31(11):1820-1836.e10. [Abstract]
- Cancer Res. 2026 Jan 22. [Abstract]
- ACS Nano. 2026 Mar 10;20(9):7679-7692. [Abstract]
- ACS Nano. 2025 Oct 21;19(41):36701-36717. [Abstract]
- ACS Nano. 2025 Aug 12;19(31):28171-28185. [Abstract]
- ACS Nano. 2023 Aug 8;17(15):15025-15043. [Abstract]
- Nat Commun. 2025 Aug 26;16(1):7961. [Abstract]
- Nat Commun. 2024 Aug 25;15(1):7319. [Abstract]
- Cell Death Differ. 2025 May 20. [Abstract]
- Acta Pharm Sin B. 2024 May;14(5):2210-2227. [Abstract]
- Adv Sci (Weinh). 2025 Sep 26:e08991. [Abstract]
- Adv Sci (Weinh). 2025 Jun 23:e05070. [Abstract]
- Adv Sci (Weinh). 2025 Mar 27:e2413709. [Abstract]
- Adv Sci (Weinh). 2025 Jan 22:e2414518. [Abstract]
- Adv Sci (Weinh). 2024 Nov 5:e2406198. [Abstract]
- Adv Sci (Weinh). 2024 Dec;11(48):e2408707. [Abstract]
- Theranostics. 2021 Mar 4;11(10):4655-4671. [Abstract]
- Chem Eng J. 2023 Dec 2, 147850.
- Chem Eng J. 15 December 2022, 138004.
- J Nanobiotechnology. 2025 Aug 6;23(1):554. [Abstract]
- J Nanobiotechnology. 2025 Jul 4;23(1):485. [Abstract]
- Small. 2025 Jul 20:e05459. [Abstract]
- Small. 2021 Aug;17(32):e2101368. [Abstract]
- Redox Biol. 2026 May:92:104086. [Abstract]
- Redox Biol. 2025 Dec:88:103917. [Abstract]
- Environ Sci Technol. 2017 Sep 19;51(18):10834-10842. [Abstract]
- Research (Wash D C). 2025 May 23:8:0703. [Abstract]
- Cell Rep Med. 2025 Apr 2:102079. [Abstract]
- Cell Mol Biol Lett. 2024 Feb 17;29(1):26. [Abstract]
- Int J Biol Sci. 2025 Jan 1;21(2):614-631. [Abstract]
- Adv Healthc Mater. 2025 Mar 20:e2405124. [Abstract]
- Acta Biomater. 2025 May 1:197:460-475. [Abstract]
- Cell Death Dis. 2025 Mar 15;16(1):177. [Abstract]
- Cell Death Dis. 2024 Mar 8;15(3):200. [Abstract]
- Cell Death Dis. 2022 Dec 12;13(12):1034. [Abstract]
- Acta Biomater. 2020 Sep 1;113:289-304. [Abstract]
- Cell Genom. 2025 Sep 25:101012. [Abstract]
- Virtual Phys Prototyp. 2024 Nov 18.
- Int J Biol Macromol. 2026 Feb;343(Pt 2):150185. [Abstract]
- Int J Biol Macromol. 2025 Dec 6;337(Pt 1):149478. [Abstract]
- Int J Biol Macromol. 2025 Dec 5;337(Pt 2):149515. [Abstract]
- Int J Biol Macromol. 2025 Apr 14;310(Pt 1):142931. [Abstract]
- Acta Pharmacol Sin. 2026 Jan 16. [Abstract]
- ACS Appl Mater Interfaces. 2026 Feb 26. [Abstract]
- Free Radic Biol Med. 2025 Aug 1:235:231-247. [Abstract]
- ACS Appl Mater Interfaces. 2024 Aug 28;16(34):45327-45336. [Abstract]
- ACS Appl Mater Interfaces. 2018 Sep 12;10(36):30081-30091. [Abstract]
- Drug Deliv. 2017 Nov;24(1):1453-1459. [Abstract]
- J Orthop Translat. 2022 Oct 17:38:23-31. [Abstract]
- Compos. Commun. . 2025 Jun.
- J Transl Med. 2026 Feb 6;24(1):152. [Abstract]
- Stem Cell Res Ther. 2021 Jan 22;12(1):77. [Abstract]
- Aging Cell. 2021 Jul;20(7):e13382. [Abstract]
- Cell Rep. 2024 Aug 30;43(9):114652. [Abstract]
- Neural Regen Res. 2023 Jun;18(6):1339-1346. [Abstract]
- Neural Regen Res. 2022 Sep;17(9):2029-2035. [Abstract]
- Int J Nanomedicine. 2025 Mar 27:20:3845-3860. [Abstract]
- J Cell Biol. 2021 Oct 4;220(10):e202011153. [Abstract]
- J Taiwan Inst Chem Eng. 2025 Nov.
- Surf Interfaces. 2025 Jan 1.
- J Agric Food Chem. 2025 Oct 22. [Abstract]
- J Agric Food Chem. 2025 Jan 8;73(1):549-561. [Abstract]
- Hum Reprod. 2025 Sep 1;40(9):1773-1785. [Abstract]
- Eur J Med Chem. 2023 Jan 5;245(Pt 2):114919. [Abstract]
- Cell Prolif. 2024 May 29:e13678. [Abstract]
- Pharmaceutics. 2026 Feb 19;18(2):259. [Abstract]
- Genome Res. 2026 Feb 3;36(2):275-290. [Abstract]
- ACS Appl Nano Mater. 2025 May 8.
- ACS Biomater Sci Eng. 2023 May 8;9(5):2545-2557. [Abstract]
- Virulence. 2026 Dec 31;17(1):2646808. [Abstract]
- Mar Drugs. 2025 Apr 22;23(5):180. [Abstract]
- Mar Drugs. 2023 Nov 21;21(12):600. [Abstract]
- J Ethnopharmacol. 2022 May 10:289:115039. [Abstract]
- Radiother Oncol. 2024 Jan:190:110039. [Abstract]
- Cells. 2022 Dec 4;11(23):3923. [Abstract]
- Nutrients. 2025 Nov 3;17(21):3463. [Abstract]
- Inflammation. 2025 Jan 30. [Abstract]
- Cellulose. 2025 Aug 20.
- Biomolecules. 2025 Feb 1;15(2):202. [Abstract]
- ACS Appl Polym Mater. 2025 Mar 26.
- Polym Compos. 2025 Feb 8.
- Int Immunopharmacol. 2025 Jan 24:148:114126. [Abstract]
- Cancer Biol Ther. 2018;19(12):1193-1203. [Abstract]
- Antimicrob Agents Chemother. 2025 Dec 5:e0144525. [Abstract]
- Nanomaterials. 2024 Sep 29;14(19):1572. [Abstract]
- Poult Sci. 2026 Mar 8;105(6):106750. [Abstract]
- FASEB J. 2025 Sep 15;39(17):e70999. [Abstract]
- Environ Toxicol Pharmacol. 2024 Mar:106:104393. [Abstract]
- J Lipid Res. 2022 May;63(5):100207. [Abstract]
- Curr Res Biotechnol. 2025.
- J Cell Physiol. 2021 Jul;236(7):5278-5292. [Abstract]
- Fish Shellfish Immunol. 2025 Aug 19:166:110672. [Abstract]
- Sci Rep. 2024 Oct 16;14(1):24223. [Abstract]
- Sci Rep. 2023 Dec 18;13(1):22598. [Abstract]
- Cell Signal. 2026 Apr:140:112360. [Abstract]
- Cell Signal. 2025 Dec 19:139:112333. [Abstract]
- AAPS J. 2025 Jun 13;27(4):109. [Abstract]
- Metab Brain Dis. 2025 Feb 15;40(2):126. [Abstract]
- Cell Cycle. 2022 Feb;21(4):352-367. [Abstract]
- Stem Cells Int. 2021 Aug 12:2021:8138374. [Abstract]
- Mol Carcinog. 2026 Apr;65(4):493-507. [Abstract]
- Hum Mol Genet. 2023 Jul 4;32(14):2326-2334. [Abstract]
- Front Biosci (Landmark Ed). 2022 Sep 13;27(9):260. [Abstract]
- J Innate Immun. 2023;15(1):262-282. [Abstract]
- Discov Oncol. 2025 Jan 9;16(1):27. [Abstract]
- Cancer Pathog Ther. 2023 Mar 7;1(2):98-110. [Abstract]
- Clin Transl Radiat Oncol. 2025 Jan 15:51:100920. [Abstract]
- PLoS One. 2026 Feb 6;21(2):e0340486. [Abstract]
- J Nat Med. 2025 Mar;79(2):371-380. [Abstract]
- Mol Biotechnol. 2024 Dec;66(12):3674-3687. [Abstract]
- J Pain Res. 2021 Feb 4;14:297-310. [Abstract]
- PeerJ. 2022 Sep 28;10:e14086. [Abstract]
- J Cardiovasc Dev Dis. 2025 Jul 21;12(7):278. [Abstract]
- Exp Ther Med. 2024 Jul 8;28(3):357. [Abstract]
- Oncol Lett. 2023 Nov 16;27(1):24. [Abstract]
- Biochem Biophys Res Commun. 2021 May 21:554:206-213. [Abstract]
- In Vitro Cell Dev Biol Anim. 2025 Aug;61(7):871-885. [Abstract]
- Braz J Med Biol Res. 2021 Jan 15;54(3):e10222. [Abstract]
- J Obstet Gynaecol Res. 2020 Sep 17;46(12):2561-2572. [Abstract]
- STAR Protoc. 2025 Sep 25;6(4):104106. [Abstract]
- Biocell. 2025 Sep 25;49(9):1711-1731.
- Pak J Pharm Sci. 2026 Jan;39(1):199-208. [Abstract]
- bioRxiv. 2026 Mar 25.
- bioRxiv. 2025 Sep 17.
- bioRxiv. 2025 February 27.
- bioRxiv. 2025 March 16.
- bioRxiv. 2025 February 07.
- Res Sq. 2024 Oct 27.
- bioRxiv. 2023 May 8.
- Chinese Pharmacological Bulletin. 2018 May; 34(5): 620-626.
-
Cell Imaging/Staining
-
IF
-
IF
-
Cell Imaging/Staining
-
Cell Imaging/Staining
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
0.98 μg/mL
Compound: 9
|
Cytotoxicity against human A549 cells assessed as reduction in cell survival after 24 hrs by resazurin assay
Cytotoxicity against human A549 cells assessed as reduction in cell survival after 24 hrs by resazurin assay
|
[PMID: 27301676] |
| BEAS-2B | IC50 |
1.95 μg/mL
Compound: 9
|
Cytotoxicity against human BEAS2B cells assessed as reduction in cell survival after 24 hrs by resazurin assay
Cytotoxicity against human BEAS2B cells assessed as reduction in cell survival after 24 hrs by resazurin assay
|
[PMID: 27301676] |
| DU-145 | IC50 |
4.25 μM
Compound: Hoechst 33342
|
Cytotoxicity against human DU145 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human DU145 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 25083189] |
| HEK293 | IC50 |
18 μM
Compound: Hoechst 33342
|
Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake incubated for 5 mins by scintillation counting
Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake incubated for 5 mins by scintillation counting
|
[PMID: 22541068] |
| HEK293 | IC50 |
19 μM
Compound: Hoechst 33342
|
Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake by scintillation counting
Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake by scintillation counting
|
[PMID: 22541068] |
| HEK293 | IC50 |
51 μM
Compound: Hoechst 33342
|
Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake incubated for 5 mins by scintillation counting
Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake incubated for 5 mins by scintillation counting
|
[PMID: 22541068] |
| HeLa | IC50 |
0.3 μM
Compound: Hoechst 33342
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 21186067] |
| KB | IC50 |
1.2 μM
Compound: HOE-33342
|
Cytotoxicity against human epidermoid carcinoma vinblastine-selected multidrug-resistant (KBV-1) cell line
Cytotoxicity against human epidermoid carcinoma vinblastine-selected multidrug-resistant (KBV-1) cell line
|
[PMID: 7658451] |
| KB 3-1 | IC50 |
0.01 μM
Compound: HOE-33342
|
Cytotoxicity against human epidermoid carcinoma (KB3-1) cell line
Cytotoxicity against human epidermoid carcinoma (KB3-1) cell line
|
[PMID: 7658451] |
| MCF7 | IC50 |
0.5 μM
Compound: Hoechst 33342
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 21186067] |
| PC-3 | IC50 |
0.71 μM
Compound: 1
|
Cytotoxicity towards prostatic carcinoma (PC3) cells in human
Cytotoxicity towards prostatic carcinoma (PC3) cells in human
|
10.1016/S0960-894X(01)80831-3 |
| RPMI 8402 | IC50 |
0.005 μM
Compound: 1
|
Cytotoxicity towards lymphoblastoma (RPMI 8402) cells in human
Cytotoxicity towards lymphoblastoma (RPMI 8402) cells in human
|
10.1016/S0960-894X(01)80831-3 |
| RPMI 8402 | IC50 |
0.03 μM
Compound: HOE-33342
|
Cytotoxicity against Human lymphoblast (RPMI 8402) cell line
Cytotoxicity against Human lymphoblast (RPMI 8402) cell line
|
[PMID: 7658451] |
| RPMI 8402 | IC50 |
0.03 μM
Compound: HOE-33342
|
Cytotoxicity against human lymphoblast cell line RPMI 8402
Cytotoxicity against human lymphoblast cell line RPMI 8402
|
[PMID: 8632422] |
| RPMI 8402 | IC50 |
0.5 μM
Compound: 1
|
Cytotoxicity towards camptothecin resistant CPT-K5 cell line in human
Cytotoxicity towards camptothecin resistant CPT-K5 cell line in human
|
10.1016/S0960-894X(01)80831-3 |
| RPMI 8402 | IC50 |
0.9 μM
Compound: HOE-33342
|
Cytotoxicity against Camptothecin-resistant (CPT -K5) cell line
Cytotoxicity against Camptothecin-resistant (CPT -K5) cell line
|
[PMID: 7658451] |
| SK-MEL | IC50 |
1.6 μM
Compound: 1
|
Cytotoxicity towards melanoma (SK-Mel) cells in human
Cytotoxicity towards melanoma (SK-Mel) cells in human
|
10.1016/S0960-894X(01)80831-3 |
| U-87MG ATCC | IC50 |
4.2 μM
Compound: Hoechst 33342
|
Cytotoxicity against human U87 cells after 72 hrs by MTT assay
Cytotoxicity against human U87 cells after 72 hrs by MTT assay
|
[PMID: 21186067] |
Guide (The following is the experimental plan we recommend. This plan serves only as a reference guide. The specific operations should be adjusted according to your actual needs.)
1. Preparation of Hoechst working solution
1.1 Preparation of storage solution
Prepare a 1 mg/mL storage solution of Hoechst using DMSO.
1.2 Preparation of working solution
Dilute the stored solution with pre-heated serum-free cell culture medium or PBS to achieve a final concentration of 10 μg/mL Hoechst working solution.
Note: Please adjust the concentration of Hoechst working solution according to the actual situation, and prepare it as needed.
2. Cell Staining (Suspension Cells)
2.1 Centrifuge to collect the cells, then add PBS for two washes, each for 5 minutes. The cell density is 1×106/mL
2.2 Add 1 mL of Hoechst working solution and incubate at room temperature for 3-10 minutes.
2.3 400 grams. Centrifuge for 3-4 minutes. Discard the supernatant.
2.4 Add PBS to wash the cells twice, for 5 minutes each time.
2.5 After resuspending the cells in 1 mL of serum-free medium or PBS, observe them using a fluorescence microscope or a flow cytometer.
3. Cytological staining (adherent cells)
3.1 Place the adherent cells on a sterile cover slip.
3.2 Remove the cover glass from the culture medium and aspirate away the excess medium.
3.3 Add 100 μL of the dye working solution and gently shake to ensure complete coverage of the cells. Incubate for 3 to 10 minutes.
3.4 Remove the dye working solution and wash with the culture medium 2-3 times, for 5 minutes each time. Observe using a fluorescence microscope or flow cytometer.
Notes:
1. Please adjust the concentration of Hoechst working solution according to the actual situation.
2. This product is exclusively for professional scientific research purposes only. It shall not be used for clinical diagnosis or treatment, nor for food or medicine purposes.
3. For your safety and health, please wear a laboratory coat and put on disposable gloves when operating.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
452
356
Chemical Information
-
CAS No. 23491-52-3
-
Appearance Solid
-
Molecular Weight 452.55
-
Formula C27H28N6O
-
Color Brown to breen
-
SMILES
CN1CCN(C2=CC=C3C(N=C(C4=CC=C5C(N=C(C6=CC=C(OCC)C=C6)N5)=C4)N3)=C2)CC1
-
Synonyms
bisBenzimide H 33342; HOE 33342
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (141)
-
Journal Impact Factor
-
Most Recent
-
Science
2025 Dec 11;390(6778):1143-1150. PMID: 41196952 -
Science
2022 Nov 18;378(6621):eabq7361. PMID: 36395215 -
Cell
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma. [Abstract]2026 Feb 5;189(3):887-905.e25. PMID: 41406964 -
Immunity
The transcription factor MEF2C restrains microglial overactivation by inhibiting kinase CDK2. [Abstract]2025 Mar 21:S1074-7613(25)00093-7. PMID: 40139186 -
Drug Resist Updat
LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein. [Abstract]2024 Jun 14:76:101111. PMID: 38908233 -
Sci Bull
2025 Aug 11:S2095-9273(25)00813-8. PMID: 40903356 -
Bioact Mater
Upconversion nanoparticles regulated drug & gas dual-effective nanoplatform for the targeting cooperated therapy of thrombus and anticoagulation. [Abstract]2022 Mar 17;18:91-103. PMID: 35387173
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: Bioact Mater. 2022 Mar 17;18:91-103. [Abstract]
The fluorescent images of HUVECs stained with NO fluorescent probe (DAF-FM DA) and Hoechst 33342 after being treated with UCATS under dark conditions or 808 nm NIR irradiation.
-
-
-
-
Cell Host Microbe
UBE2O-mediated monoubiquitination licenses NLRP6 inflammasome activation in the intestine. [Abstract]2026 Jan 14;34(1):86-102.e8. PMID: 41500221 -
Cell Host Microbe
Mycobacterium tuberculosis suppresses host DNA repair to boost its intracellular survival. [Abstract]2023 Nov 8;31(11):1820-1836.e10. PMID: 37848028 -
Cancer Res
ETC-501 is a Brain Penetrant MNK Kinase Inhibitor that Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy. [Abstract]2026 Jan 22. PMID: 41570320 -
ACS Nano
Topology Outweighs Stiffness: Self-Reinforced Cell Mechanotransduction via Multiaxial Curvature Engineering of Ultrasoft Hydrogels. [Abstract]2026 Mar 10;20(9):7679-7692. PMID: 41733433 -
ACS Nano
A CRISPR-Customizable Copper-Coordinated DNA Nanoplatform Potentiates Cuproptosis Through Circadian and Metabolic Pathway Manipulation. [Abstract]2025 Oct 21;19(41):36701-36717. PMID: 41071600 -
ACS Nano
A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung Cancer. [Abstract]2025 Aug 12;19(31):28171-28185. PMID: 40728393 -
ACS Nano
Biomimetic Mineralized CRISPR/Cas RNA Nanoparticles for Efficient Tumor-Specific Multiplex Gene Editing. [Abstract]2023 Aug 8;17(15):15025-15043. PMID: 37481734 -
Nat Commun
2025 Aug 26;16(1):7961. PMID: 40858572 -
Nat Commun
2024 Aug 25;15(1):7319. PMID: 39183339 -
Cell Death Differ
GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62. [Abstract]2025 May 20. PMID: 40394165 -
Acta Pharm Sin B
Rhizoma Drynariae-derived nanovesicles reverse osteoporosis by potentiating osteogenic differentiation of human bone marrow mesenchymal stem cells via targeting ER α signaling. [Abstract]2024 May;14(5):2210-2227. PMID: 38799625 -
Adv Sci (Weinh)
Acetylation of the Mitochondrial Chaperone GRP75 Governs ER-Mitochondrial Calcium Homeostasis and Hepatocyte Insulin Resistance. [Abstract]2025 Sep 26:e08991. PMID: 41001747 -
Adv Sci (Weinh)
Lysosome-Featured Cell Aggregate-Released Extracellular Vesicles Regulate Iron Homeostasis and Alleviate Post-Irradiation Endothelial Ferroptosis for Mandibular Regeneration. [Abstract]2025 Jun 23:e05070. PMID: 40546115 -
Adv Sci (Weinh)
UGDH Lactylation Aggravates Osteoarthritis by Suppressing Glycosaminoglycan Synthesis and Orchestrating Nucleocytoplasmic Transport to Activate MAPK Signaling. [Abstract]2025 Mar 27:e2413709. PMID: 40150862 -
Adv Sci (Weinh)
Ischemic Area-Targeting and Self-Monitoring Nanoprobes Ameliorate Myocardial Ischemia/Reperfusion Injury by Scavenging ROS and Counteracting Cardiac Inflammation. [Abstract]2025 Jan 22:e2414518. PMID: 39840521 -
Adv Sci (Weinh)
Catalytically Active Ti-Based Nanomaterials for Hydroxyl Radical Mediated Clinical X-Ray Enhancement. [Abstract]2024 Nov 5:e2406198. PMID: 39501581 -
Adv Sci (Weinh)
Patient-Derived Melanoma Immune-Tumoroids as a Platform for Precise High throughput Drug Screening. [Abstract]2024 Dec;11(48):e2408707. PMID: 39475010 -
Theranostics
Aurka loss in CD19+ B cells promotes megakaryocytopoiesis via IL-6/STAT3 signaling-mediated thrombopoietin production. [Abstract]2021 Mar 4;11(10):4655-4671. PMID: 33754019
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: Theranostics. 2021 Mar 4;11(10):4655-4671. [Abstract]
Hoechst 33342 (10 µg/mL) is added to the medium of cultured megakaryocytes for 2 h at 37°C. Cells are stained with the directly coupled monoclonal antibodies PE-anti-CD41 and APC-anti-Mpl for 30 min at 4°C. Ploidy is measured in the CD41+Mpl+ cell population.
-
-
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: Chem Eng J. 15 December 2022, 138004.
Apoptotic cells in four groups were stained with Hoechst 33342 (for 10 min) reflected by bright blue nuclei, including hP-MSCs cultured on noncoated, L-Gel-coated (10 nM), and D-Gel coated (10 nM) plates under exposure of 500 μM H2O2 for 5 h except for the normal group, and PBS as control.
-
J Nanobiotechnology
Intravesical delivery of mucoadhesive and tumor-selective-penetrating nanozymes for enhancing the PDT of bladder cancer. [Abstract]2025 Aug 6;23(1):554. PMID: 40770338 -
J Nanobiotechnology
SIRT5-modified human umbilical cord mesenchymal stem cells loaded with antioxidant polydopamine nanozyme enhance parpi resistance in ovarian cancer via fatty acid metabolism reprogramming. [Abstract]2025 Jul 4;23(1):485. PMID: 40616128 -
Small
2025 Jul 20:e05459. PMID: 40685792 -
Small
A Ferrocene-Functionalized Covalent Organic Framework for Enhancing Chemodynamic Therapy via Redox Dyshomeostasis. [Abstract]2021 Aug;17(32):e2101368. PMID: 34216420 -
Redox Biol
USP20 governs tyrosine kinase inhibitors resistance through ferroptosis evasion by targeting GPX4 in cancers. [Abstract]2026 May:92:104086. PMID: 41844497 -
Redox Biol
Oxidative modification of G-quadruplex triggers CLIC4-associated mitochondrial dysfunction to promote glioblastoma progression. [Abstract]2025 Dec:88:103917. PMID: 41265251 -
Environ Sci Technol
Cytotoxicity and Efflux Pump Inhibition Induced by Molybdenum Disulfide and Boron Nitride Nanomaterials with Sheetlike Structure. [Abstract]2017 Sep 19;51(18):10834-10842. PMID: 28841301 -
Research (Wash D C)
Targeting the Exonic Circular OGT RNA/O-GlcNAc Transferase/Forkhead Box C1 Axis Inhibits Asparagine- and Alanine-Mediated Ferroptosis Repression in Neuroblastoma Progression. [Abstract]2025 May 23:8:0703. PMID: 40416363 -
Cell Rep Med
Microneedle delivery of CAR-M-like engineered macrophages alleviates intervertebral disc degeneration through enhanced efferocytosis capacity. [Abstract]2025 Apr 2:102079. PMID: 40199328 -
Cell Mol Biol Lett
High-content image screening to identify chemical modulators for peroxisome and ferroptosis. [Abstract]2024 Feb 17;29(1):26. PMID: 38368371 -
Int J Biol Sci
HIF-2α/LPCAT1 orchestrates the reprogramming of lipid metabolism in ccRCC by modulating the FBXW7-mediated ubiquitination of ACLY. [Abstract]2025 Jan 1;21(2):614-631. PMID: 39781455 -
Adv Healthc Mater
Engineered Hollow Nanocomplex Combining Photothermal and Antioxidant Strategies for Targeted Tregs Depletion and Potent Immune Activation in Tumor Immunotherapy. [Abstract]2025 Mar 20:e2405124. PMID: 40109122 -
Acta Biomater
Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy. [Abstract]2025 May 1:197:460-475. PMID: 40113021 -
Cell Death Dis
CKMT1 deficiency contributes to mitochondrial dysfunction and promotes intestinal epithelial cell apoptosis via reverse electron transfer-derived ROS in colitis. [Abstract]2025 Mar 15;16(1):177. PMID: 40089459 -
Cell Death Dis
p66Shc signaling and autophagy impact on C2C12 myoblast differentiation during senescence. [Abstract]2024 Mar 8;15(3):200. PMID: 38459002
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Mar 8;15(3):200. [Abstract]
C2C12 Cells were incubated with 1.25 μM MitoSOX in HBSS Ca/Mg for 10 min in dark at 37 °C with a 5% CO2 atmosphere. Then, cell nuclei were stained by incubating with 1 µg/mL Hoechst in HBSS, for 10 min at 37 °C in the dark, with a 5% CO2 atmosphere.
-
Cell Death Dis
Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein. [Abstract]2022 Dec 12;13(12):1034. PMID: 36509750 -
Acta Biomater
A nitric oxide-releasing hydrogel for enhancing the therapeutic effects of mesenchymal stem cell therapy for hindlimb ischemia. [Abstract]2020 Sep 1;113:289-304. PMID: 32663662
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: Acta Biomater. 2020 Sep 1;113:289-304. [Abstract]
Hoechst 33342 staining (for 6 h) is used to distinguish apoptotic changes in H2O2-treated hP-MSCs.
-
Cell Genom
2025 Sep 25:101012. PMID: 41005306 -
-
Int J Biol Macromol
Zinc-α₂-glycoprotein overexpression attenuates gasdermin D-mediated pyroptosis in dopaminergic neurons by suppressing reactive oxygen species/mitogen-activated protein kinase signaling. [Abstract]2026 Feb;343(Pt 2):150185. PMID: 41520969 -
Int J Biol Macromol
Cancer cell membrane-biomimetic and antioxidant-powered nanoplatform for overcoming multidrug resistance in triple-negative breast cancer. [Abstract]2025 Dec 6;337(Pt 1):149478. PMID: 41360238 -
Int J Biol Macromol
3-Carboxyphenylboronic acid functionalized polydopamine-coated cellulose nanocrystals as a pH-responsive nanocarrier for targeted curcumin delivery. [Abstract]2025 Dec 5;337(Pt 2):149515. PMID: 41352493 -
Int J Biol Macromol
Forskolin-loaded carboxymethyl chitosan and silk nonofiber hydrogels composite scaffolds improve skin regeneration. [Abstract]2025 Apr 14;310(Pt 1):142931. PMID: 40239781 -
Acta Pharmacol Sin
PLN-L31A/I40A for the treatment of inherited heart disease caused by PLN-R14del mutations. [Abstract]2026 Jan 16. PMID: 41545752 -
ACS Appl Mater Interfaces
A Near-Infrared Emitting Aggregation-Induced Emission Photosensitizer with Endoplasmic Reticulum Targeting Ability for Breast Cancer Photodynamic Therapy. [Abstract]2026 Feb 26. PMID: 41747230 -
Free Radic Biol Med
Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation. [Abstract]2025 Aug 1:235:231-247. PMID: 40316059 -
ACS Appl Mater Interfaces
Aptamer-Loop DNA Nanoflower Recognition and Multicolor Fluorescent Carbon Quantum Dots Labeling System for Multitarget Living Cell Imaging. [Abstract]2024 Aug 28;16(34):45327-45336. PMID: 39161311 -
ACS Appl Mater Interfaces
Enhanced Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment. [Abstract]2018 Sep 12;10(36):30081-30091. PMID: 30118197
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: ACS Appl Mater Interfaces. 2018 Sep 12;10(36):30081-30091. [Abstract]
Hoechst 33342 (10 min) staining shows the survival of HUVECs administrated 100 μg/mL exosomes or CS-Exo upon exposure to 400 μM H2O2.
-
Drug Deliv
2017 Nov;24(1):1453-1459. PMID: 28949254 -
J Orthop Translat
2022 Oct 17:38:23-31. PMID: 36313979
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: J Orthop Translat. 2022 Oct 17:38:23-31. [Abstract]
OBs (red) and OCs were co-cultured, FAM-SGPA (green) were added to culture dish, incubated for 24 h, labelled the nucleus with Hoechst 33342 (blue, 15 min), and observed under a confocal laser scanning microscope (magnification: 630 × ).
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: J Orthop Translat. 2022 Oct 17:38:23-31. [Abstract]
FAM-SGPA (green) interfered with OBs for 0.5 h, 1 h, 2 h and 4 h, labelled the nucleus with Hoechst 33342 (blue, 15 min), and observed under a confocal laser scanning microscope (magnification: 400 × ).
-
-
J Transl Med
Cathepsin H as a causal risk factor and therapeutic target in proliferative diabetic retinopathy. [Abstract]2026 Feb 6;24(1):152. PMID: 41652421 -
Stem Cell Res Ther
The delivery of hsa-miR-11401 by extracellular vesicles can relieve doxorubicin-induced mesenchymal stem cell apoptosis. [Abstract]2021 Jan 22;12(1):77. PMID: 33482923
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: Stem Cell Res Ther. 2021 Jan 22;12(1):77. [Abstract]
To evaluate the anti-apoptosis property of extracellular vesicles from hP-MSCs, the Hoechst 33342 (for 10 min) is used to distinguish the apoptotic cells in the three different groups.
-
Aging Cell
C/EBP homologous protein deficiency enhances hematopoietic stem cell function via reducing ATF3/ROS-induced cell apoptosis. [Abstract]2021 Jul;20(7):e13382. PMID: 34128315 -
Cell Rep
Beyond mitochondrial transfer, cell fusion rescues metabolic dysfunction and boosts malignancy in adenoid cystic carcinoma. [Abstract]2024 Aug 30;43(9):114652. PMID: 39217612 -
Neural Regen Res
Thrombin increases the expression of cholesterol 25-hydroxylase in rat astrocytes after spinal cord injury. [Abstract]2023 Jun;18(6):1339-1346. PMID: 36453421 -
Neural Regen Res
2022 Sep;17(9):2029-2035. PMID: 35142693 -
Int J Nanomedicine
Dual-Mode Treatment of Hepatocellular Carcinoma Using RGD Cyclopeptide-Modified Liposomes Loaded with Ce6/DOX. [Abstract]2025 Mar 27:20:3845-3860. PMID: 40165796 -
J Cell Biol
Loss of centromeric RNA activates the spindle assembly checkpoint in mammalian female meiosis I. [Abstract]2021 Oct 4;220(10):e202011153. PMID: 34379093
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: J Cell Biol. 2021 Oct 4;220(10):e202011153. [Abstract]
The released centromere parts are marked by arrows (blue: Hoechst; green: MajSAT-mClover; red: H2B-mCherry). Chromatin was briefly counterstained with Hoechst 33342 (5 µg/mL) before imaging. Scale bar: 5 µm (yellow) and 2 µm (white).
-
-
-
J Agric Food Chem
Profiling Class-Wide Bioactivities of Flavonoids While Minimizing Compound-Specific Effects Using an Equimolar Mixture Strategy. [Abstract]2025 Oct 22. PMID: 41126446 -
J Agric Food Chem
A Disintegrin and Metalloproteinase 17 Disrupts Bovine Macrophage MER Proto-Oncogene Tyrosine Kinase Integrity to Impede Apoptotic Cell Clearance and Promote Inflammation in Clinical Mastitis. [Abstract]2025 Jan 8;73(1):549-561. PMID: 39731564 -
Hum Reprod
Pathogenic variants in DLGAP5 cause female infertility characterized by oocyte maturation arrest and embryonic arrest. [Abstract]2025 Sep 1;40(9):1773-1785. PMID: 40639803 -
Eur J Med Chem
Development of novel oridonin analogs as specifically targeted NLRP3 inflammasome inhibitors for the treatment of dextran sulfate sodium-induced colitis. [Abstract]2023 Jan 5;245(Pt 2):114919. PMID: 36399877 -
Cell Prolif
Tetrahedral framework nucleic acid-based small-molecule inhibitor delivery for ecological prevention of biofilm. [Abstract]2024 May 29:e13678. PMID: 38812355 -
Pharmaceutics
Ganoderma lucidum Polysaccharide Potentiates mRNA-LNP Efficacy: Synergizing Oxidative Stress Mitigation with Innate Immune Modulation. [Abstract]2026 Feb 19;18(2):259. PMID: 41755000 -
Genome Res
Transcriptomic landscape of transposable elements reveals LTR7- PLAAT4 as a potential oncogene and therapeutic target in pancreatic adenocarcinoma. [Abstract]2026 Feb 3;36(2):275-290. PMID: 41506784 -
-
ACS Biomater Sci Eng
Biomimetic Biomembrane Encapsulation and Targeted Delivery of a Nitric Oxide Release Platform for Therapy of Parkinson's Disease. [Abstract]2023 May 8;9(5):2545-2557. PMID: 37040524 -
Virulence
Antibacterial efficacy and mechanism of the novel antimicrobial peptide lachnospirin-1 against Acinetobacter baumannii. [Abstract]2026 Dec 31;17(1):2646808. PMID: 41838520 -
Mar Drugs
Low-Molecular-Weight Fucoidan Inhibits Thromboinflammation and Ameliorates Deep Vein Thrombosis via Targeting S100A8/A9. [Abstract]2025 Apr 22;23(5):180. PMID: 40422770 -
Mar Drugs
Ascomylactam C Induces an Immunogenic Cell Death Signature via Mitochondria-Associated ER Stress in Lung Cancer and Melanoma. [Abstract]2023 Nov 21;21(12):600. PMID: 38132921 -
J Ethnopharmacol
Quercus acutissima Carruth. root extract triggers apoptosis, autophagy and inhibits cell viability in breast cancer cells. [Abstract]2022 May 10:289:115039. PMID: 35092826
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: J Ethnopharmacol. 2022 May 10:289:115039. [Abstract]
MCF-7 cells were treated with QA root extract for 48 h and observed by fluorescence microscopy after Hoechst 33342 trihydrochloride (Hoechst, 1 μg/mL; 10 min) staining. Scale bar 100 μm.
-
Radiother Oncol
Targeting the survival kinase DYRK1B: A novel approach to overcome radiotherapy-related treatment resistance. [Abstract]2024 Jan:190:110039. PMID: 38040123 -
Cells
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS. [Abstract]2022 Dec 4;11(23):3923. PMID: 36497181 -
Nutrients
A Proanthocyanidins-Rich Cili (Rosa roxburghii) Fruit Extract Protects CCl4-Induced Mouse Hepatic Fibrosis via Modulation of Ferroptosis and Gut Microbiota. [Abstract]2025 Nov 3;17(21):3463. PMID: 41228535 -
Inflammation
Exploring the Role of TRAF6-TAK1 Pathway in Podocyte Pyroptosis and Its Implications for Primary Membranous Nephropathy Therapy. [Abstract]2025 Jan 30. PMID: 39883393 -
-
Biomolecules
2025 Feb 1;15(2):202. PMID: 40001505 -
-
-
Int Immunopharmacol
Anti-osteosarcoma activity of Corynoline via Src/JNK signaling-mediated cell cycle arrest and mitochondrial apoptosis. [Abstract]2025 Jan 24:148:114126. PMID: 39862636 -
Cancer Biol Ther
2018;19(12):1193-1203. PMID: 30081723
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: Cancer Biol Ther. 2018;19(12):1193-1203. [Abstract]
PC-3 stable subline cells as indicated (empty vector or CRMP4a) were seeded on cover glass in full culture media for 24 h and then stained with iFluor555-conjugated phalloidin (red) and Hoechst33342 (blue). Cells were also subjected to immunocytofluorescent staining with anti-vinculin antibodies (green) followed by visualization with AlexaFluor®488-labeld secondary antibodies. The representative microscopic images were shown from four independent experiments.
-
Antimicrob Agents Chemother
Repurposing epetraborole to combat Neisseria gonorrhoeae and Chlamydia trachomatis infections. [Abstract]2025 Dec 5:e0144525. PMID: 41347518 -
Nanomaterials
2D MXene Nanosheets with ROS Scavenging Ability Effectively Delay Osteoarthritis Progression. [Abstract]2024 Sep 29;14(19):1572. PMID: 39404298 -
Poult Sci
Paeonol alleviates granulosa cell senescence in laying chickens via the PI3K/Akt/mTOR signaling pathway. [Abstract]2026 Mar 8;105(6):106750. PMID: 41846081 -
FASEB J
ApoE Mimetic Peptide-MsrA Fusion Protein Restores HDL Function and Ameliorates Atherosclerosis via Circulatory Redox Remodeling in SR-BI Deficient Mice. [Abstract]2025 Sep 15;39(17):e70999. PMID: 40888010 -
Environ Toxicol Pharmacol
2024 Mar:106:104393. PMID: 38367920 -
J Lipid Res
Intravital lipid droplet labeling and imaging reveals the phenotypes and functions of individual macrophages in vivo. [Abstract]2022 May;63(5):100207. PMID: 35398040
Hoechst 33342 purchased from MedChemExpress. Usage Cited in: J Lipid Res. 2022 May;63(5):100207. [Abstract]
The labeling efficiency of BODIPY-loaded PLGA NPs in vitro. Fluorescence confocal images of labeled LDs in macrophages; LDs (green color, BODIPY) and nuclei (blue color, Hoechst 33342 (2 μg/mL; 2 min)); the scale bar represents 25 μm.
-
-
J Cell Physiol
TGF-β/Alk5 signaling prevents osteoarthritis initiation via regulating the senescence of articular cartilage stem cells. [Abstract]2021 Jul;236(7):5278-5292. PMID: 33452687 -
Fish Shellfish Immunol
Teleost-specific TLR25/MyD88 signaling promotes K63-linked ubiquitination of IRF1 to induce IFNa gene expression. [Abstract]2025 Aug 19:166:110672. PMID: 40840666 -
Sci Rep
Elevated circulating LncRNA NORAD fosters endothelial cell growth and averts ferroptosis by modulating the miR-106a/CCND1 axis in CAD patients. [Abstract]2024 Oct 16;14(1):24223. PMID: 39414920 -
Sci Rep
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. [Abstract]2023 Dec 18;13(1):22598. PMID: 38114514 -
Cell Signal
Ophiopogonis japonicus polysaccharide inhibits oxidative stress in hepatocytes by promoting Runx3 in nonalcoholic fatty liver disease. [Abstract]2026 Apr:140:112360. PMID: 41520744 -
Cell Signal
PERK-eIF2alpha-mediated translational inhibition of MCL-1 contributes to potential 2-deoxy-D-glucose and BAD mimetic combinatorial cancer therapy. [Abstract]2025 Dec 19:139:112333. PMID: 41423011 -
AAPS J
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic Modeling. [Abstract]2025 Jun 13;27(4):109. PMID: 40514581 -
Metab Brain Dis
α-asarone activates mitophagy to relieve diabetic encephalopathy via inhibiting apoptosis and oxidative stress. [Abstract]2025 Feb 15;40(2):126. PMID: 39954135 -
Cell Cycle
Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis. [Abstract]2022 Feb;21(4):352-367. PMID: 34974799 -
Stem Cells Int
Gli1+ Cells Residing in Bone Sutures Respond to Mechanical Force via IP3R to Mediate Osteogenesis. [Abstract]2021 Aug 12:2021:8138374. PMID: 34434241 -
Mol Carcinog
Integrated Analysis Reveals ZNF184 as a Novel Regulator of Stemness-Associated Paclitaxel Resistance and Tumor Progression in Breast Cancer. [Abstract]2026 Apr;65(4):493-507. PMID: 41642732 -
Hum Mol Genet
2023 Jul 4;32(14):2326-2334. PMID: 37133443 -
Front Biosci (Landmark Ed)
LncRNA-SUSAJ1 Activates the ER Stress Pathway Inhibiting JEV Proliferation by Promoting PK15 Cells Apoptosis. [Abstract]2022 Sep 13;27(9):260. PMID: 36224019 -
J Innate Immun
MCPIP-1-Mediated Immunosuppression of Neutrophils Exacerbates Acute Bacterial Peritonitis and Liver Injury. [Abstract]2023;15(1):262-282. PMID: 36273448 -
Discov Oncol
MUC5B regulates alterations in the immune microenvironment in nasopharyngeal carcinoma via the Wnt/β-catenin signaling pathway. [Abstract]2025 Jan 9;16(1):27. PMID: 39786598 -
Cancer Pathog Ther
Dachaihu decoction inhibits hypernutrition-induced liver metastasis from colorectal cancer by maintaining the gut vascular barrier. [Abstract]2023 Mar 7;1(2):98-110. PMID: 38328407 -
Clin Transl Radiat Oncol
Live-cell imaging and analysis of 3D spheroids in hypoxia- and radiotherapy-related research. [Abstract]2025 Jan 15:51:100920. PMID: 39898333 -
PLoS One
Screening a library of antibacterial compounds leads to discovery of novel inhibitors for Neisseria gonorrhoeae and Chlamydia trachomatis. [Abstract]2026 Feb 6;21(2):e0340486. PMID: 41649981 -
J Nat Med
Ellagic acid prevents ovariectomy-induced bone loss and attenuates oxidative damage of osteoblasts by activating SIRT1. [Abstract]2025 Mar;79(2):371-380. PMID: 39702722 -
Mol Biotechnol
2024 Dec;66(12):3674-3687. PMID: 38040933 -
J Pain Res
Exosome-Encapsulated microRNA-127-3p Released from Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Osteoarthritis Through Regulating CDH11-Mediated Wnt/β-Catenin Pathway. [Abstract]2021 Feb 4;14:297-310. PMID: 33574696 -
PeerJ
Ac2-26 attenuates hepatic ischemia-reperfusion injury in mice via regulating IL-22/IL-22R1/STAT3 signaling. [Abstract]2022 Sep 28;10:e14086. PMID: 36193422 -
J Cardiovasc Dev Dis
Nuclear Lactate Dehydrogenase A Resists Cardiomyocyte Cell Cycle Arrest Induced by Oxidative Stress. [Abstract]2025 Jul 21;12(7):278. PMID: 40710803 -
Exp Ther Med
GATA2‑miR‑374a axis promotes vascular smooth muscle cells proliferation, migration via targeting circTADA2A/RORA axis. [Abstract]2024 Jul 8;28(3):357. PMID: 39071901 -
Oncol Lett
Exosome‑delivered miR‑486‑3p inhibits the progression of osteosarcoma via sponging CircKEAP1/MARCH1 axis components. [Abstract]2023 Nov 16;27(1):24. PMID: 38058466 -
Biochem Biophys Res Commun
Tideglusib suppresses stem-cell-like features and progression of osteosarcoma by inhibiting GSK-3β/NOTCH1 signaling. [Abstract]2021 May 21:554:206-213. PMID: 33813076 -
In Vitro Cell Dev Biol Anim
Overexpression of MEOX2 inhibits breast cancer cell metastasis by targeting oxidative stress-induced RGS5. [Abstract]2025 Aug;61(7):871-885. PMID: 40603753 -
Braz J Med Biol Res
Suppressive effect of platycodin D on bladder cancer through microRNA-129-5p-mediated PABPC1/PI3K/AKT axis inactivation. [Abstract]2021 Jan 15;54(3):e10222. PMID: 33470388 -
J Obstet Gynaecol Res
Exosomal microRNA-139-5p from mesenchymal stem cells accelerates trophoblast cell invasion and migration by motivation of the ERK/MMP-2 pathway via downregulation of protein tyrosine phosphatase. [Abstract]2020 Sep 17;46(12):2561-2572. PMID: 32945060 -
STAR Protoc
Protocol for quantifying PARP inhibitor-induced changes in PARP1 dynamics and activity through live-cell imaging. [Abstract]2025 Sep 25;6(4):104106. PMID: 41014565 -
-
Pak J Pharm Sci
2026 Jan;39(1):199-208. PMID: 41482789 -
-
-
-
-
-
-
-
Solvent & Solubility
DMSO : 10 mg/mL (22.10 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : < 0.1 mg/mL (insoluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocol
Labeling Nuclear DNA with Hoechst 33342[1] Step 1, Dilute the Hoechst stock solution 1:100 in H2O for use in labeling. Step 2, Aspirate the cell medium from cells grown on coverslips. Rinse the cells three times with PBS+. Step 3, Incubate the cells in the Hoechst labeling solution (from Step 1) for 10-30 min at room temperature. Step 4, Aspirate the labeling solution. Rinse the cells three times in PBS+. Step 5, Mount the coverslips. Step 6, Image the cells (λex ~353 nm, λem ~483 nm for Hoechst 33342)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.2097 mL | 11.0485 mL | 22.0970 mL | 55.2425 mL |
| 5 mM | 0.4419 mL | 2.2097 mL | 4.4194 mL | 11.0485 mL | |
| 10 mM | 0.2210 mL | 1.1049 mL | 2.2097 mL | 5.5243 mL | |
| 15 mM | 0.1473 mL | 0.7366 mL | 1.4731 mL | 3.6828 mL | |
| 20 mM | 0.1105 mL | 0.5524 mL | 1.1049 mL | 2.7621 mL |